Blood Clot News and Research

RSS

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

Resveratrol antioxidant found in red wine may benefit heart tissue

New research on rat heart cells suggests that a well-known antioxidant found in red wine, called resveratrol, may benefit heart tissue by limiting the effects of a condition called cardiac fibrosis.

8 Dec 2004

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

The combination of two pills -- thalidomide and dexamethasone -- may be an effective alternative to the intravenous chemotherapy commonly prescribed to patients with multiple myeloma, according to a large collaborative study conducted by the Eastern Cooperative Oncology Group and led by a Mayo Clinic investigator.

7 Dec 2004

New clues in understanding why group A streptococci (GAS) has a range of bacterial afflictions in humans

Researchers have unlocked new clues in understanding why group A streptococci (GAS) has a range of bacterial afflictions in humans. One of the keys to this species of bacteria is its production of streptokinase (SK), an enzyme that activates plasminogen, the blood clot-dissolving protein in humans.

6 Dec 2004

New insight into anticoagulation therapies

Anticoagulation therapies, or treatments that reduce the amount of clotting factors in the blood, are quite common and used for a variety of reasons.

6 Dec 2004

Novel mutagenesis screen used to identify genetic suppressors of thrombosis

Researchers using a novel sensitized ENU (N-ethyl-N-nitrosourea, a carcinogen-induced animal tumor model established to grow malignant and benign tumors) mutagenesis (induction of mutation) screen in laboratory mice have developed a promising approach to genetic screening that can increase the likelihood of identifying dominant suppressors of thrombosis.

6 Dec 2004

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

5 Dec 2004

Implications of twin, triplet and quadruplet pregnancies on mothers

More women giving birth in their later years has given rise to fertility treatments which has in turn led to what can be described as an explosion in twin, triplets and quadruplet pregnancies.

4 Dec 2004

Study focused on patients with chemotherapy-related anemia

Findings from an interim analysis of a new study comparing the hemoglobin response rates of Epoetin alfa and darbepoetin alfa in the treatment of chemotherapy-related anemia were published in the November 15, 2004 issue of the Medical Journal 'Blood' as part of the American Society of Hematology 46th Annual Meeting and Exposition.

4 Dec 2004

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries, according to a study in Circulation: Journal of the American Heart Association.

24 Nov 2004

SSRI's increase risk of abnormal bleeding

New users of selective serotonin reuptake inhibitors (SSRIs, a type of antidepressant) have an increased risk of being admitted to the hospital for abnormal bleeding, according to an article in the November 22 issue of The Archives of Internal Medicine.

23 Nov 2004

Overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) reduces tumor growth

Scientists have found that overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) blocks the formation of new blood vessels and thus reduces tumor growth. Therapeutics based on this finding may potentially lead to new cancer treatments.

19 Nov 2004

Not only are breast enhancement pills unproven, they could be dangerous

Flip through any women's magazine and you are sure to find advertisements hawking pills to enlarge women's breasts. But do these pills actually work? Probably not, says the American Society of Plastic Surgeons (ASPS).

18 Nov 2004

Patented fibrin-based matrices and tissue may open doors for tissue and organ engineering

Virginia Commonwealth University engineers and scientists have developed and patented a unique technique to grow three-dimensional tissues and organs in a mold made from material the human body naturally uses to repair wounds, potentially eliminating the chance for rejection.

17 Nov 2004

Five advanced tests provide answers to couples with unexplained infertility

For couples struggling with infertility, "all routine tests came back negative" are not the words they want to hear. With up to 15% of couples with "unexplained infertility" and another 3% struggling with recurrent pregnancy loss, advanced tests help doctors find answers for their most challenging cases.

16 Nov 2004

Heart bypass gets new source for replacement blood vessels

The search for a stable, renewable source of blood vessels, especially for potential use in heart bypass surgery, has reached a milestone at the State University of New York at Buffalo.

11 Nov 2004

Sirolimus drug-coated stent causes less inflammation than bare metal stents

In the treatment of coronary artery disease, a sirolimus drug-coated stent causes less inflammation than bare metal stents, according to preliminary research presented at the American Heart Association annual meeting by Loyola University Health System, Maywood, Ill.

11 Nov 2004

Heavy drinking after suffering a heart attack doubles risk of dying

Heavily drinking – or binging – even intermittently, almost doubles a person’s risk of dying after a heart attack, compared to that of a moderate drinker, according, to a first-of-its-kind study, reported at the American Heart Association’s Scientific Sessions 2004.

11 Nov 2004

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

A major Canadian-led global study has found that an inexpensive anti-blood-clotting drug significantly reduces death and repeat heart attacks without increasing the risk of stroke.

8 Nov 2004

Coronary stents have no impact on mortality over the long term

While the placement of stents in newly reopened coronary arteries has been shown to reduce the need for repeat angioplasty procedures, researchers from the Duke Clinical Research Institute have found that stents have no impact on mortality over the long term.

8 Nov 2004

Hormone therapy findings suggest a complex relationship between marketing, scientific evidence and prescribing patterns

Pharmaceutical companies slashed their promotional spending for hormone therapies by more than a third following reports in July 2002 of health risks associated with the drugs, but within the year they beefed up their marketing efforts to promote lower-dose forms of the medications

1 Nov 2004

Blood Clot News and Research

Further Reading

Resveratrol antioxidant found in red wine may benefit heart tissue

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

New clues in understanding why group A streptococci (GAS) has a range of bacterial afflictions in humans

New insight into anticoagulation therapies

Novel mutagenesis screen used to identify genetic suppressors of thrombosis

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

Implications of twin, triplet and quadruplet pregnancies on mothers

Study focused on patients with chemotherapy-related anemia

Bypass surgery on a beating heart is an excellent option for many patients with blocked heart arteries

SSRI's increase risk of abnormal bleeding

Overexpression of a protein called Down Syndrome Critical Region 1 (DSCR-1) reduces tumor growth

Not only are breast enhancement pills unproven, they could be dangerous

Patented fibrin-based matrices and tissue may open doors for tissue and organ engineering

Five advanced tests provide answers to couples with unexplained infertility

Heart bypass gets new source for replacement blood vessels

Sirolimus drug-coated stent causes less inflammation than bare metal stents

Heavy drinking after suffering a heart attack doubles risk of dying

Reviparin significantly reduces death and repeat heart attacks without increasing the risk of stroke

Coronary stents have no impact on mortality over the long term

Hormone therapy findings suggest a complex relationship between marketing, scientific evidence and prescribing patterns

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News